JPMorgan Chase & Co’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,069
| Closed | -$13K | – | 5222 |
|
|
2020
Q2 | $13K | Buy |
+5,069
| New | +$13K | ﹤0.01% | 4480 |
|
|
2019
Q4 | – | Sell |
-6,068
| Closed | -$32K | – | 4971 |
|
|
2019
Q3 | $32K | Buy |
6,068
+247
| +4% | +$1.3K | ﹤0.01% | 4386 |
|
|
2019
Q2 | $56K | Buy |
5,821
+5,177
| +804% | +$49.8K | ﹤0.01% | 4212 |
|
|
2019
Q1 | $17K | Sell |
644
-30,760
| -98% | -$812K | ﹤0.01% | 4539 |
|
|
2018
Q4 | $709K | Buy |
31,404
+1,160
| +4% | +$26.2K | ﹤0.01% | 3213 |
|
|
2018
Q3 | $1.67M | Sell |
30,244
-831
| -3% | -$45.9K | ﹤0.01% | 2876 |
|
|
2018
Q2 | $2.22M | Buy |
31,075
+24,289
| +358% | +$1.73M | ﹤0.01% | 2751 |
|
|
2018
Q1 | $417K | Sell |
6,786
-51,633
| -88% | -$3.17M | ﹤0.01% | 3440 |
|
|
2017
Q4 | $7.36M | Sell |
58,419
-1,546
| -3% | -$195K | ﹤0.01% | 1999 |
|
|
2017
Q3 | $7.92M | Buy |
+59,965
| New | +$7.92M | ﹤0.01% | 1890 |
|
|
2017
Q2 | – | Sell |
-1,156
| Closed | -$212K | – | 4621 |
|
|
2017
Q1 | $212K | Buy |
1,156
+542
| +88% | +$99.4K | ﹤0.01% | 3466 |
|
|
2016
Q4 | $49K | Buy |
614
+561
| +1,058% | +$44.8K | ﹤0.01% | 4025 |
|
|
2016
Q3 | $4K | Sell |
53
-51
| -49% | -$3.85K | ﹤0.01% | 3945 |
|
|
2016
Q2 | $9K | Buy |
104
+95
| +1,056% | +$8.22K | ﹤0.01% | 3848 |
|
|
2016
Q1 | $1K | Sell |
9
-1
| -10% | -$111 | ﹤0.01% | 4103 |
|
|
2015
Q4 | $3K | Buy |
+10
| New | +$3K | ﹤0.01% | 3866 |
|
|
2014
Q2 | – | Sell |
-1,470
| Closed | -$320K | – | 3555 |
|
|
2014
Q1 | $320K | Buy |
+1,470
| New | +$320K | ﹤0.01% | 3198 |
|